Letroheal-2.5 Tablet is primarily used to manage certain types of breast cancer in women who have ceased menstruation. This medicine forms part of a group known as aromatase inhibitors.
In addition to its main use, Letroheal is also prescribed for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. It's used as an extended adjuvant treatment in early breast cancer cases where women have previously received standard adjuvant tamoxifen therapy. Moreover, it serves as a first-line and second-line tool for managing hormone receptor-positive or unknown advanced breast cancer in postmenopausal women.
Before you start taking this medication, consult your doctor for the correct dosage and frequency. It's crucial to inform your doctor about any pre-existing conditions or current medications that you are on. If you notice any side effects while on this medication, report them to your doctor immediately. For optimal results, continue taking the medication for the duration prescribed by your doctor.